variou
type
viral
vaccin
develop
last
centuri
wide
spectrum
efficaci
safeti
manufactur
convent
attenu
inactiv
subunit
requir
cultur
infecti
virus
cell
substrat
despit
dedic
effort
convent
cell
cultur
often
fail
produc
suffici
amount
viru
evalu
immunogen
protect
efficaci
safeti
viral
vaccin
moreov
emerg
virus
caus
highmort
rate
without
option
treatment
prophylaxi
necessit
manipul
manufactur
stringent
biosafeti
environ
surprisingli
altern
technolog
circumv
limit
high
prioriti
area
vaccin
develop
product
nanoparticl
np
viruslik
particl
vlp
assembl
multimer
peptid
provid
attract
platform
vaccin
design
viruslik
particl
np
structur
resembl
infecti
virion
noninfecti
due
lack
viral
genom
recombin
surfac
antigen
natur
virion
assembl
highli
order
conform
empti
particl
devoid
genet
materi
antigen
epitop
present
multival
highli
repetit
outer
structur
np
lead
crosslink
bcell
receptor
induct
longlast
immun
respons
mimick
morpholog
natur
infecti
virion
regularli
assembl
particl
highli
immunogen
amen
diagnost
prophylact
exploit
among
simplest
target
vlp
nonenvelop
virus
hepat
e
viru
human
papilloma
viru
compos
pure
viral
capsid
protein
contrast
nonenvelop
virus
virion
assembl
exclus
capsid
protein
envelop
virus
eg
coronaviru
flaviviru
requir
addit
membran
compon
assembl
matur
virion
consequ
envelop
vlp
assembl
matrix
protein
provid
molecular
scaffold
viral
antigen
embed
lipid
membran
differ
type
glycoprotein
may
embed
lipid
membran
target
antigen
gener
immunolog
respons
howev
process
requir
multipl
protein
surfac
antigen
matrix
protein
envelop
vlp
structur
uniform
difficult
character
promis
altern
present
target
antigen
surfac
selfassembl
np
lieu
lipid
membran
serv
macromolecular
scaffold
present
antigen
interest
develop
np
vaccin
consider
given
regard
select
robust
faith
system
np
assembl
enabl
costeffect
develop
deliveri
vaccin
time
manner
structurebas
approach
silico
underli
principl
rel
advanc
np
assembl
approach
consid
thermodynam
stabil
final
assembl
np
without
due
recognit
kinet
complex
control
regular
assemblag
random
interact
lead
misfold
aggreg
therefor
surpris
engin
np
refractori
solubl
express
present
practic
challeng
product
laboratoryscal
commerci
manufactur
process
problem
becom
augment
express
bacteri
host
lack
fold
assist
bacteri
cytoplasm
viral
antigen
therefor
due
advantag
assist
fold
posttransl
modif
possibl
gener
multiplecompon
np
vlp
eukaryot
host
yeast
insect
mammalian
cell
favor
bacteri
host
howev
system
significantli
expens
bacteri
system
timeconsum
downstream
process
usual
complex
moreov
purif
vlp
insect
cell
system
pose
challeng
due
similar
physicochem
properti
vlp
baculovirus
bacteri
system
avail
would
provid
costeffect
mean
develop
deliv
vaccin
well
serodiagnost
antigen
kit
use
diagnosespecif
infect
diseas
middl
east
respiratori
syndrom
mer
first
report
saudi
arabia
caus
multipl
case
infect
high
mortal
europ
asia
mer
caus
merscoronaviru
merscov
transmit
camel
human
human
human
worldwid
transmiss
increas
direct
household
communitywid
transmiss
well
nosocomi
set
exemplifi
outbreak
korea
neither
effect
vaccin
therapeut
intervent
current
avail
assembl
merscov
antigen
immunolog
relev
conform
np
would
interest
may
help
develop
vaccin
serodiagnost
tool
therapeut
monoclon
antibodi
current
studi
present
novel
bacteri
np
merscov
antigen
use
ferritin
molecular
scaffold
selfassembl
ferritin
present
live
organ
ident
subunit
spontan
selfassembl
form
np
complex
intern
extern
diamet
nm
respect
previou
studi
show
ferritin
helicobact
pylori
human
isol
use
scaffold
hiv
influenza
np
vaccin
use
eukaryot
host
cell
human
embryon
kidney
cell
likewis
bacterioferritin
fr
selfassembl
nanocag
octahedr
symmetri
also
evalu
potenti
drug
deliveri
system
howev
viral
antigen
human
pathogen
prone
misfold
aggreg
necessit
chemic
refold
insolubl
aggreg
order
regain
solubl
allow
regular
assembl
antigen
addit
display
antigen
surfac
multimolecularli
assembl
scaffold
bacteri
host
remain
daunt
challeng
hypothes
np
display
receptorbind
domain
rbd
spike
protein
merscov
could
produc
bacteri
system
har
function
molecular
chaperon
convent
protein
fold
prevent
nonfunct
aggreg
ascrib
molecular
chaperon
recent
shown
rna
molecul
abl
provid
novel
function
molecular
chaperon
base
novel
find
concept
chaperna
chaperon
rna
function
establish
report
chaperna
function
har
fold
assembl
hybrid
ferritin
monom
np
use
bacteri
express
system
also
demonstr
biophys
properti
includ
solubl
yield
stabil
merscov
np
could
improv
properli
control
rnabind
affin
concentr
salt
chapernabas
np
assembl
may
prove
versatil
tool
develop
deliv
recombin
vaccin
serolog
detect
emergingreemerg
virus
anim
research
perform
accord
guidelin
ministri
food
drug
safeti
republ
korea
experi
approv
ylarc
institut
anim
care
use
committe
iacuc
permit
number
sixweekold
femal
balbc
mice
purchas
orient
bio
inc
seoul
korea
sera
recov
mer
patient
use
ethic
approv
grant
institut
review
board
chungnam
nation
univers
hospit
irb
seoul
nation
univers
hospit
irb
studi
perform
accord
ethic
standard
laid
declar
helsinki
subsequ
revis
inform
consent
obtain
patient
particip
studi
express
vector
pgehrid
construct
parent
vector
pgelysr
pgelysr
vector
enzymat
cut
ndei
kpni
pcr
product
hrid
carri
tev
proteas
cleavag
site
tag
cterminu
cut
use
restrict
enzym
digest
fragment
insert
vector
gener
pgehrid
fr
genebank
access
dna
synthes
purchas
cosmo
genetech
korea
dna
cleav
sali
hindiii
insert
pgehrid
gener
hrid
fr
receptor
bind
domain
rbd
ntermin
residu
merscov
protein
genbank
access
gener
gene
synthesi
cut
kpni
sali
insert
hridfr
gener
pgehrid
rbdfr
linker
ssg
asg
insert
cterminu
rbd
use
overlap
pcr
cleav
kpni
sai
ligat
hridfr
gener
pgehrid
rbd
ssg
fr
pgehrid
rbd
asg
fr
respect
schemat
diagram
express
vector
illustr
figur
gene
mutant
hrid
hrid
gener
gene
synthesi
cleav
ndei
kpni
insert
pgehrid
rbdfr
gener
pgehrid
rbdfr
pgehrid
rbdfr
respect
mutat
site
amino
acid
sequenc
mutant
shown
tabl
supplementari
materi
result
express
vector
transform
escherichia
coli
strain
cell
grown
ml
lb
medium
ampicillin
overnight
type
transform
inocul
ml
lb
medium
ampicillin
grown
optic
densiti
reach
protein
express
induc
mm
iptg
h
sampl
harvest
centrifug
lyse
sonic
lysi
buffer
mm
ph
glycerol
mm
solubl
fraction
lysat
purifi
niaffin
hp
column
atka
prime
ge
healthcar
concentr
merck
millipor
ltd
purifi
protein
treat
tev
proteas
remov
fusion
partner
hrid
assembl
np
purifi
gel
filtrat
increas
column
ge
healthcar
homolog
model
fusion
complex
merscov
rbd
fr
gener
model
version
sali
lab
california
use
data
protein
data
base
pdb
merscov
rbd
pdb
id
code
bacteri
ferritin
pdb
id
code
templat
linker
domain
improv
use
refin
loop
domain
energyst
model
rbdfr
rbd
ssg
fr
rbd
asg
fr
rbd
fr
trimer
structur
format
predict
use
multim
dock
softwar
cluspro
abc
group
structur
bioinformat
lab
boston
univers
stoni
brook
univers
thermodynam
stabil
calcul
use
cluspro
formula
coeffici
weight
e
examin
size
structur
purifi
np
microscop
evalu
use
tem
cryoem
perform
tem
analysi
drop
np
place
onto
formvarcarbonco
tem
grid
spl
grid
neg
stain
uranyl
acet
dri
examin
use
electron
microscop
jeol
acceler
voltag
kv
particl
size
calcul
use
cameramegaview
iii
soft
imag
systemgermani
measur
np
random
imag
field
cryoem
np
place
onto
plasmatr
formvarcarbon
copper
grid
em
neg
stain
uranyl
acet
grid
acceler
kv
fei
cryotecnai
cryoem
microscop
made
avail
korean
institut
scienc
technolog
np
examin
photograph
high
resolut
nanoparticl
sampl
ml
place
dispoh
cell
analyz
use
zetapotenti
particl
size
analyz
otsuka
electron
intens
distribut
diamet
np
measur
twice
water
solvent
sampl
accumul
time
cultur
cell
ml
lyse
lysi
buffer
presenc
variou
concentr
nacl
mm
evalu
intracellular
protein
sampl
perform
triplic
cell
lysat
separ
solubl
insolubl
fraction
centrifug
protein
stabil
analyz
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
thu
protein
cell
lysat
ml
cultur
purifi
use
ninta
resin
thermo
fisher
scientif
buffer
depend
nacl
concentr
mm
evalu
effect
np
format
cell
cultur
lb
media
variou
concentr
np
format
examin
size
exclus
chromatographi
sec
sdspage
tem
dl
variou
concentr
nacl
cell
harvest
sonic
lysi
buffer
separ
solubl
pellet
fraction
centrifug
target
protein
solubl
fraction
purifi
use
ninta
resin
thermo
fisher
scientif
follow
manufactur
instruct
total
lysat
solubl
fraction
p
pellet
fraction
w
wash
fraction
e
elut
fraction
analyz
sdspage
copurif
nucleic
acid
protein
wash
elut
analyz
nativ
agaros
gel
nucleic
acid
visual
ethidium
bromid
etbr
protein
coomassi
stain
cultur
cell
ml
harvest
use
method
describ
cell
lyse
protein
extract
reagent
ii
thermo
scientif
separ
solubl
pellet
fraction
centrifug
rpm
aliquot
solubl
fraction
treat
rnase
intron
biotechnolog
incub
min
nucleas
treat
sampl
clarifi
centrifug
rpm
min
solubl
supernat
pellet
precipit
analyz
sdspage
gel
follow
western
blot
analysi
confirm
proper
fold
rbdfr
variant
rbd
ssg
fr
bind
purifi
protein
merscov
receptor
perform
elisa
fr
phosphatebuff
salin
pb
use
neg
control
nunc
microtit
immunopl
thermo
fisher
scientif
coat
ngwell
protein
abcam
incub
overnight
plate
wash
block
block
buffer
bsa
h
room
temperatur
rbd
ssg
linker
wt
fr
ngwell
ad
h
antipenta
antibodi
qiagen
serial
dilut
tbst
mm
ph
ad
well
incub
h
secondari
goat
antimous
igg
antibodi
conjug
hrp
volum
sigmaaldrich
ad
incub
h
plate
wash
three
time
tbst
end
step
wash
substrat
tmb
solut
bd
bioscienc
ad
well
plate
incub
min
dark
stop
solut
n
ad
well
stop
colorimetr
reaction
absorb
nm
measur
use
elisa
reader
fluostar
optima
bmg
labtech
well
micropl
nunc
roskild
denmark
coat
ng
four
protein
rbd
ssg
fr
rbdfr
wt
rbdfr
rbdfr
incub
overnight
merscov
rbd
protein
eenzym
use
posit
control
follow
subsequ
step
well
wash
three
time
buffer
sigmaaldrich
st
loui
mo
usa
coat
antigen
remov
well
block
pbst
skim
milk
pb
h
h
block
solut
remov
twofold
serial
dilut
sera
four
patient
ad
well
incub
h
antigenco
well
incub
peroxidaseconjug
goat
antihuman
igg
antibodi
kpl
seracar
life
scienc
milford
usa
h
primari
antibodi
remov
tmb
sigmaaldrich
ad
well
colorimetr
substrat
immedi
treatment
reaction
stop
solut
sigmaaldrich
od
read
nm
sixweekold
femal
balbc
mice
immun
rbdfr
rbd
ssg
fr
rbd
protein
gener
describ
commerci
avail
merscov
rbd
protein
eenzym
antigen
facil
ylarc
antigen
dilut
pb
first
group
equal
volum
adjuv
addavax
cat
mix
pipet
group
equal
volum
antigen
alum
adjuv
thermo
fisher
scientif
mix
pipet
follow
manufactur
protocol
pb
plu
adjuv
fr
use
neg
control
immun
mice
boost
twice
intramuscular
inject
day
mice
anesthet
day
ocular
bleed
orbit
sinu
figur
supplementari
materi
immun
sera
process
centrifug
collect
blood
g
min
spleen
balf
bronchoalveolar
lavag
obtain
day
last
immun
sacrif
mice
balf
taken
wash
airway
ml
pb
tcell
popul
immun
mice
analyz
flow
cytometr
analysi
spleen
taken
day
last
immun
sacrif
mice
obtain
singlecel
suspens
tissu
homogen
pass
cell
strainer
spl
centrifug
erythrocyt
remov
red
blood
cell
lyse
buffer
sigma
cell
wash
resuspend
iscov
modifi
dulbecco
media
contain
fb
intracellular
cytokin
stain
splenocyt
stimul
rbd
protein
phorbol
myrist
acetateionomycin
presenc
ngml
recombin
human
biolegend
brefeldin
ebiosci
h
stimul
cell
block
rat
antimous
bd
bioscienc
surfac
stain
fitc
clone
biolegend
clone
biolegend
min
stain
cell
fix
fac
lyse
solut
bd
bioscienc
room
temperatur
min
permeabil
fac
buffer
fb
pb
contain
saponin
sigma
room
temperatur
min
cell
stain
pe
clone
biolegend
apc
clone
biolegend
room
temperatur
min
data
collect
bd
lsr
fortessa
bd
bioscienc
analyz
flowjo
softwar
tree
star
inc
ashland
usa
competit
elisa
perform
determin
whether
merscov
antigen
rbd
ssg
fr
rbdfr
rbd
fr
neg
control
immun
mous
serum
inhibit
bind
rbd
protein
receptor
ngwell
protein
abcam
coat
nunc
microtit
immunopl
thermo
fisher
scientif
incub
overnight
plate
wash
block
block
buffer
skim
milk
pb
pbst
h
time
mous
sera
immun
rbd
rbd
ssg
fr
rbdfr
fr
serial
dilut
ngwell
rbd
protein
eenzym
tbst
mm
triscl
ph
ad
new
well
incub
h
solut
ad
well
incub
h
tag
antibodi
conjug
horseradish
peroxidas
thermo
fisher
scientif
ad
well
incub
h
plate
wash
three
time
tbst
substrat
tmb
solut
bd
bioscienc
incub
min
dark
stop
solut
n
ad
well
stop
color
reaction
measur
absorb
nm
use
elisa
reader
fluostar
optima
bmg
labtech
spike
glycoprotein
merscov
use
gener
merscovlik
np
protein
form
trimer
result
larg
spike
viru
envelop
challeng
express
fullsiz
protein
kda
e
coli
thu
domain
protein
kda
includ
receptorbind
abil
use
initi
attempt
express
domain
either
fusion
protein
fail
express
level
solubl
protein
lower
limit
detect
sdspage
western
blot
figur
supplementari
materi
therefor
use
rbd
aa
protein
pivot
function
illustr
figur
express
alon
e
coli
rbd
abl
form
trimer
assembl
unpublish
observ
due
lack
domain
within
domain
overcom
problem
fr
use
scaffold
assembl
fr
spheric
np
whose
subunit
form
trimer
subsequ
result
octahedr
structur
compos
ident
subunit
therefor
perform
comput
model
evalu
potenti
fr
scaffold
trimer
format
rbd
possibl
trimer
format
analyz
comput
model
use
model
cluspro
variou
linker
includ
ssg
asg
introduc
rbd
fr
goal
minim
steric
hindranc
two
domain
enhanc
trimer
np
format
silico
analysi
show
energyst
trimer
model
rbdfr
rbd
ssg
fr
rbd
asg
fr
wherea
fail
form
trimer
structur
figur
rbd
ssg
fr
predict
stabl
wellstructur
compar
rbdfr
rbd
asg
fr
initi
test
rbdfr
construct
without
hrid
fusion
show
none
construct
solubl
express
even
lowtemperatur
cultur
condit
figur
rbdfr
rbd
ssg
fr
respect
addit
yield
purifi
rbdfr
l
cultur
protein
lowsolubl
express
merscov
rbd
fuse
hrid
nterminu
rbdfr
chapernabas
fusion
partner
figur
previous
confirm
use
chaperna
globular
domain
influenza
hemagglutinin
ha
effici
assembl
trimer
complex
immunolog
relev
conform
yang
et
al
press
shown
figur
hrid
fusion
significantli
increas
solubl
rbdfr
rbd
ssg
fr
indic
chaperna
platform
effect
increas
solubl
fold
fuse
target
protein
poor
express
level
low
solubl
rbd
asg
fr
construct
figur
experi
perform
use
rbdfr
rbd
ssg
fr
construct
purif
solubl
protein
figur
supplementari
materi
determin
potenti
effect
use
hrid
fusion
partner
selfassembl
np
shown
figur
supplementari
materi
hridrbdfr
fail
form
np
perform
tev
proteas
cleavag
hrid
remov
hrid
domain
facilit
selfassembl
rbdfr
monom
also
elimin
immun
respons
nonself
hrid
domain
balbc
mice
figur
supplementari
materi
hrid
cleavag
rbdfr
rbd
ssg
fr
purifi
use
sec
figur
expect
rbd
ssg
fr
assembl
properli
form
np
kda
effici
rbdfr
np
mainli
detect
voidvolum
fraction
suggest
irregularli
assembl
solubl
aggreg
size
rbd
ssg
fr
np
confirm
tem
tem
imag
rbd
ssg
fr
np
structur
show
hollow
spheric
particl
compact
rbdfr
np
averag
diamet
rbd
ssg
fr
np
nm
figur
contrast
dl
analysi
rbdfr
np
structur
without
ssg
linker
appear
smaller
averag
intens
diamet
nm
compar
rbd
ssg
fr
averag
intens
distribut
diamet
nm
figur
consist
sec
analysi
rbdfr
without
fusion
partner
mostli
produc
solubl
aggreg
form
therefor
identifi
protein
fold
occur
properli
without
hrid
format
np
confirm
sec
sdspage
analys
shown
figur
supplementari
materi
purifi
np
retain
stabil
extend
period
time
variou
temperatur
thu
result
indic
ssg
linker
allow
rbdfr
gener
properli
assembl
np
also
note
effici
protein
fold
np
format
may
enhanc
appropri
linker
select
report
ionic
strength
play
import
role
stabil
selfassembl
ferritin
examin
effect
salt
concentr
format
stabil
rbd
ssg
fr
np
variou
concentr
mm
consist
previou
studi
stabil
protein
highli
affect
concentr
nacl
lysi
buffer
sdspage
figur
n
solubl
protein
significantli
decreas
concentr
nacl
increas
mm
solubl
lower
mm
compar
mm
unlik
previou
studi
solubl
protein
gradual
recov
higher
nacl
concentr
mm
solubl
mm
higher
mm
furthermor
yield
solubl
protein
per
liter
cultur
increas
salt
concentrationdepend
manner
figur
investig
effect
salt
concentr
physicochem
morpholog
properti
rbd
ssg
fr
protein
examin
sec
tem
dl
mm
nacl
protein
aggreg
purif
process
purifi
protein
fail
form
spheric
structur
instead
exist
predominantli
kda
monom
figur
figur
supplementari
materi
contrast
protein
lyse
mm
nacl
purifi
mm
nacl
develop
wellstructur
np
accord
tem
dl
analys
figur
figur
supplementari
materi
howev
base
sec
analysi
highsalt
concentr
mm
protein
fail
form
stabl
structur
protein
elut
predominantli
void
volum
suggest
solubl
aggreg
highsalt
concentr
figur
transmiss
electron
microscopi
imag
variou
salt
concentr
clearli
support
conclus
show
tendenc
aggreg
depend
salt
concentr
figur
taken
togeth
result
underscor
import
salt
concentr
solubl
monom
qualiti
multimer
assembl
hybrid
np
ferritin
intrins
abil
interact
form
ferritiniron
core
thu
worth
investig
effect
assembl
stabil
rbd
ssg
fr
np
cell
grown
lb
medium
variou
concentr
shown
figur
yield
purifi
protein
significantli
increas
cultur
reflect
increas
compar
similar
cultur
cell
growth
purif
yield
slightli
decreas
presum
due
toxic
ferric
acid
np
format
variou
concentr
analyz
sec
figur
consist
previou
result
protein
elut
mainli
fraction
expect
size
assembl
np
kda
note
ratio
np
solubl
aggreg
sec
analysi
show
np
format
facilit
high
concentr
figur
format
rbd
ssg
fr
np
concentr
confirm
tem
figur
dl
figur
tem
analysi
clearli
show
morpholog
protein
compact
probabl
highli
stabl
assembl
high
concentr
lower
concentr
figur
shown
figur
averag
diamet
np
examin
dl
nm
high
concentr
nm
lower
concentr
result
suggest
salt
concentr
influenc
effici
qualiti
regular
assembl
hybrid
ferritin
monom
np
previou
studi
show
interact
crucial
transduc
chaperon
function
rna
fold
client
protein
consist
present
studi
show
rna
facilit
fold
interact
protein
solubl
hrid
wt
rbdfr
higher
rbdfr
without
hrid
fusion
figur
strongli
support
previou
studi
addit
solubl
rbd
alon
complet
insolubl
figur
figur
supplementari
materi
shown
posit
charg
residu
lysin
moieti
hrid
contribut
trna
bind
current
studi
trna
bind
induc
intrins
disord
protein
idp
statu
hrid
form
alphahel
structur
figur
thu
two
rnabind
mutant
doublemut
hrid
nonamut
hrid
construct
tabl
supplementari
materi
total
e
coli
lysat
fraction
solubl
fraction
pellet
fraction
p
centrifug
expect
rbd
rbdfr
without
fusion
hrid
domain
refractori
produc
solubl
protein
figur
interestingli
solubl
rnabind
mutant
decreas
actual
increas
mutant
mutant
compar
wildtyp
protein
figur
consid
hrid
rel
unstructur
absenc
trna
bind
result
consist
previou
report
fusion
idp
promot
solubl
target
protein
follow
purif
wildtyp
hridrbdfr
hrid
wt
rbdfr
electrophoret
mobil
shift
assay
show
greater
amount
nucleic
acid
copurifi
hrid
wt
rbdfr
protein
mutant
hridrbdfr
nondenatur
condit
figur
rel
ratio
nucleic
acid
base
etbr
stain
protein
base
coomassi
stain
elut
fraction
confirm
reduc
affin
mutant
nucleic
acid
test
rna
role
maintain
stabil
target
protein
lysat
treat
rnase
elimin
rna
solubl
protein
analyz
sdspage
western
blot
solubl
fraction
lysat
incub
presenc
absenc
rnase
sampl
separ
solubl
fraction
insolubl
fraction
centrifug
shown
left
panel
figur
rnase
treatment
complet
abolish
effect
rna
protein
solubl
compar
control
rnase
sampl
prior
rnase
treatment
parallel
experi
mutant
show
much
less
rna
copurifi
protein
confirm
reduc
affin
nucleic
acid
complet
deplet
rna
rnase
treatment
figur
left
panel
remark
solubl
hrid
wt
rbdfr
greatli
reduc
deplet
rna
reflect
ratio
rnase
rnase
respect
coomassi
stain
western
blot
analys
figur
right
panel
howev
solubl
mutant
significantli
affect
rnase
treatment
probabl
due
lower
affin
rna
figur
right
panel
taken
togeth
result
demonstr
hrid
wt
rbdfr
maintain
strong
affin
rna
affin
pivot
maintain
solubl
protein
defin
rna
depend
solubl
ferritin
hybrid
figur
investig
rna
bind
role
format
np
rbdfr
variou
hridrbdfr
wt
protein
purifi
nickelaffin
chromatographi
figur
supplementari
materi
physicochem
properti
analyz
sec
figur
tem
figur
dl
figur
solubl
yield
rbdfr
hrid
fusion
approxim
mgl
cultur
repres
greater
higher
level
hrid
counterpart
cultur
confirm
role
hrid
robust
enhanc
solubl
assembl
strike
note
two
mutant
protein
despit
high
solubl
figur
detect
disproportion
higher
amount
void
fraction
sec
indic
fail
form
np
defin
size
exist
predominantli
solubl
aggreg
figur
howev
hrid
wt
rbdfr
predominantli
form
np
defin
size
kda
also
interest
note
slight
shift
rnabind
mutant
elut
pattern
suggest
larger
size
np
compar
wildtyp
np
overal
ratio
solubl
aggreg
void
volum
np
defin
size
clearli
show
rna
bind
crucial
assembl
monom
np
control
rbdfr
without
hrid
fusion
exist
predominantli
solubl
aggreg
figur
supplementari
materi
consist
result
em
analysi
confirm
wellstructur
np
hrid
wt
rbdfr
compar
larg
aggreg
structur
mutant
protein
figur
even
multimolecular
structur
form
structur
becom
unstabl
mostli
solubl
aggreg
consist
intens
distribut
diamet
wildtyp
protein
estim
dl
analysi
nm
compar
larger
size
hrid
nm
hrid
nm
figur
figur
supplementari
materi
conceiv
solubl
aggreg
may
shield
expos
tag
result
decreas
bind
affin
nickel
resin
elut
earlier
fraction
compar
wt
protein
figur
supplementari
materi
taken
togeth
data
demonstr
rna
bind
prevent
aggreg
irregular
conform
guid
selfassembl
hybrid
ferritin
monom
np
stabl
structur
immunolog
properti
ferritin
np
analyz
elisa
human
receptor
previous
identifi
receptor
merscov
human
infect
therefor
use
coat
antigen
elisabind
assay
rbd
np
receptor
perform
figur
fr
without
rbd
fusion
fail
bind
similar
pb
neg
control
strikingli
bind
abil
increas
order
rnabind
abil
hrid
wt
highest
absorb
observ
wt
ssg
linker
hrid
wt
rbd
ssg
fr
result
show
conform
rbd
wt
np
better
resembl
protect
antigen
merscov
rbd
cell
compar
rnabind
mutant
judici
choic
linker
ferritin
carrier
antigen
import
receptor
bind
reflect
import
np
assembl
stabl
conform
figur
final
elisa
result
np
human
patient
investig
use
sera
four
merscovinfect
patient
figur
six
differ
protein
includ
five
recombin
np
hrid
wt
rbdfr
hrid
rbdfr
hrid
rbdfr
hrid
wt
rbd
ssg
fr
fr
merscov
rbd
protein
compar
elisa
use
captur
antigen
strong
elisa
signal
detect
four
recombin
np
merscov
rbd
cell
posit
control
wt
form
consist
show
higher
respons
rnabind
mutant
hrid
wt
hrid
wt
rbd
ssg
fr
best
binder
among
construct
test
result
address
util
e
coli
assembl
merscov
rbdfr
np
use
tool
serodiagnosi
merscov
infect
taken
togeth
result
confirm
immunolog
relev
conform
merscov
rbd
display
hybrid
ferritin
particl
crucial
role
rna
control
kinet
pathway
assembl
viral
antigen
monom
stabl
np
evalu
immunogen
ferritinbas
np
balbc
mice
n
immun
rbd
rbdfr
rbd
ssg
fr
np
antigen
trna
found
remov
hrid
protein
purif
process
immun
potenti
rna
contamin
purifi
protein
determin
gel
electrophoresi
shown
figur
supplementari
materi
rna
detect
level
sever
purif
step
compar
protein
purifi
first
step
previous
alumadjuv
merscov
antigen
report
increas
antibodi
tcell
respons
mice
thu
first
group
second
group
immun
twice
antigen
contain
equal
volum
alum
respect
figur
supplementari
materi
collect
serum
rbdspecif
igg
titer
analyz
elisa
alum
adjuv
rbd
ssg
fr
np
rbdfr
np
induc
higher
p
rbd
figur
antibodi
titer
adjuv
rbd
ssg
fr
np
rbdfr
np
higher
rbd
respect
antibodi
respons
rbdfr
rbd
ssg
fr
np
much
stronger
rbd
antibodi
subtyp
test
figur
test
mucos
immun
respons
rbdspecif
iga
antibodi
level
balf
also
analyz
elisa
figur
adjuv
rbd
ssg
fr
np
present
significantli
higher
od
valu
rbd
fr
neg
control
result
suggest
rbd
ssg
fr
np
induc
local
mucos
immun
respons
stronger
rbd
addit
confirm
antibodi
respons
igg
antigen
higher
alumadjuv
antigen
contrast
pb
fr
control
group
fail
weakli
induc
antibodi
respons
rbd
protein
result
suggest
frbase
np
significantli
enhanc
variou
antibodi
respons
monomer
antigen
cellular
immun
respons
investig
mice
immun
protein
rbd
rbdfr
rbd
ssg
fr
fr
neg
control
splenocyt
mice
n
harvest
week
last
immun
stimul
rbd
protein
analyz
cytokin
flow
cytometri
rbdimmun
group
tcell
respons
detect
low
level
howev
cell
significantli
increas
rbdfr
rbd
ssg
frimmun
group
compar
rbd
frimmun
group
figur
supplementari
materi
result
demonstr
rbd
np
vaccin
induc
antigenspecif
cell
produc
upon
antigen
stimul
middl
east
respiratori
syndromecoronaviru
infect
mediat
interact
rbd
host
receptor
correl
protect
competit
elisa
perform
investig
whether
antibodi
gener
np
immun
abl
interfer
bind
thu
incub
rbd
protein
mous
serum
bind
serummix
sampl
protein
measur
shown
figur
rbd
ssg
fr
rbdfr
rbdimmun
sera
strongli
abolish
bind
rbd
receptor
respect
interestingli
rel
effici
interfer
correl
np
assemblag
figur
contrast
frimmun
mous
serum
neg
control
fail
inhibit
interact
take
togeth
result
demonstr
immun
np
greatli
stimul
merscovspecif
antibodi
respons
effect
interfer
cellular
receptor
bind
suggest
possibl
vaccin
howev
protect
efficaci
ultim
test
live
viru
challeng
model
key
immunolog
featur
like
highli
repetit
nanostructur
provid
design
principl
np
induc
potent
longlast
antibodi
respons
vlp
nonenvelop
virus
assembl
made
pure
capsid
protein
envelop
virus
howev
addit
membran
compon
matrix
protein
requir
display
target
antigen
surfac
assembl
vlp
promis
altern
present
target
antigen
surfac
selfassembl
np
lieu
lipid
membran
matrix
protein
serv
macromolecular
scaffold
present
antigen
interest
ferritin
substitut
matrix
protein
membran
use
scaffold
regular
assembl
target
antigen
howev
ferritinbas
np
produc
host
cell
mammalian
insect
origin
previous
show
influenza
ha
could
assembl
solubl
trimer
immunolog
relev
conform
exploit
chaperna
activ
present
studi
first
report
use
rna
molecular
chaperon
supramolecular
structur
present
novel
bacteri
system
np
assembl
hybrid
ferritin
display
surfac
antigen
merscov
np
react
strongli
sera
deriv
merscovinfect
patient
figur
confirm
util
serodiagnosi
infect
moreov
antisera
gener
immun
mice
abl
interfer
bind
cellular
receptor
figur
part
essenti
protect
immun
respons
effici
receptorbind
inhibit
figur
well
abil
induc
mucos
respons
figur
correl
regular
assembl
np
examin
dl
em
figur
confirm
present
antigen
epitop
multival
highli
repetit
structur
inde
import
qualiti
immun
respons
overal
qualiti
np
consequ
immun
respons
govern
rnamedi
assembl
antigen
hypothes
chaperna
function
could
har
present
target
antigen
highli
repetit
nanostructur
figur
hrid
ntermin
domain
hlysr
previous
identifi
nucleic
acidbind
domain
figur
report
hrid
exploit
transduc
chaperna
function
tcf
serv
dockingtag
cellular
rna
foldingassembl
hybrid
fr
contain
client
antigen
protein
rbd
merscov
figur
advantag
use
hrid
tcf
could
mani
fold
first
hrid
small
kda
monomer
flexibl
enough
allow
access
sitespecif
proteas
remov
hrid
figur
supplementari
materi
note
hrid
belong
idp
switch
stabil
upon
bind
trna
second
bound
rna
due
highli
neg
charg
may
resist
uncontrol
intermolecular
interact
among
monom
amorph
aggreg
final
even
nake
hrid
absenc
rna
bind
due
intrins
flexibl
natur
may
pose
physic
hindranc
multipl
interact
among
monom
enabl
assembl
stabl
superstructur
upon
remov
hrid
thu
potenti
pacemak
function
har
rna
molecul
allow
regular
assembl
monom
highli
repetit
nanostructur
consequ
current
studi
hybrid
fr
produc
solubl
form
could
purifi
onestep
affin
chromatographi
remark
assembl
np
defin
size
upon
remov
hrid
figur
supplementari
materi
consist
principl
design
loss
rna
bind
hrid
significantli
hamper
regular
assembl
ferritin
monom
increas
amount
nonfunct
misfold
protein
solubl
aggreg
figur
thu
overal
yield
well
qualiti
np
depend
chaperna
function
transduc
hrid
turn
mediat
interact
cellular
rna
like
trna
drive
control
factor
de
novo
assembl
biomolecul
poorli
understood
histor
host
factor
like
groel
initi
discov
molecular
chaperon
support
viral
growth
e
coli
support
assembl
viral
capsid
protein
moreov
groel
also
cooper
rbcx
plant
cell
assembl
multicompon
rubisco
abund
protein
biospher
respons
photosynthesi
therefor
intrigu
rna
could
provid
robust
foldingassembl
supramolecular
structur
recent
confirm
present
strategi
could
success
appli
assembl
bacteri
synthes
monom
noroviru
vlp
compos
monom
unpublish
observ
seong
bl
whether
rna
substitut
collabor
preexist
proteinbas
molecular
chaperon
remain
excit
avenu
futur
investig
note
defin
versatil
function
expand
rna
molecul
engin
system
har
chaperna
function
present
report
may
prove
tip
iceberg
pivot
function
rna
molecul
chaperon
fold
supramolecular
assembl
protein
live
organ
variou
factor
identifi
import
effici
assembl
merscov
np
extrins
factor
bind
affin
hrid
cellular
rna
crucial
assembl
qualiti
assembl
np
figur
intrins
factor
concentr
salt
also
influenc
assembl
stabil
np
figur
ionic
strength
play
import
role
stabil
selfassembl
ferritin
aggreg
increas
increas
concentr
nacl
assembl
hybrid
merscov
np
reveal
interest
chang
salt
depend
mm
nacl
buffer
optim
condit
confirm
em
dl
analys
figur
chang
salt
depend
probabl
due
presenc
electrostat
interact
among
rbd
domain
depend
surpris
consid
ferritin
intrins
abil
interact
form
ferritiniron
core
base
experi
enhanc
qualiti
np
advis
control
concentr
cultur
bacteri
cell
purif
solubl
monom
protein
figur
first
yield
purifi
protein
increas
presenc
figur
greater
compar
control
condit
lack
second
ratio
np
solubl
aggreg
sec
show
np
format
facilit
high
concentr
result
compact
morpholog
em
figur
c
thu
overal
yield
qualiti
np
govern
intrins
abil
interact
final
data
show
presenc
natur
linker
ferritin
rbd
antigen
also
import
assembl
np
possibl
linker
flexibl
suffici
length
would
accommod
steric
requir
assembl
multimer
np
howev
difficult
precis
predict
effect
linker
therefor
advis
screen
multipl
construct
earli
stage
test
assembl
np
display
antigen
interest
conclus
chapernabas
antigen
assembl
platform
hold
promis
develop
deliveri
npbase
vaccin
enhanc
rbdspecif
antibodi
respons
serolog
detect
emerg
virus
variou
type
design
principl
advanc
structurebas
approach
np
assembl
howev
silico
method
consid
thermodynam
stabil
final
assembl
np
necessarili
kinet
pathway
lead
success
fold
regular
assemblag
consequ
np
refractori
solubl
express
fail
assembl
design
result
signific
practic
challeng
manufactur
process
chapernamedi
fold
pacekeep
assembl
monom
higher
order
structur
enabl
faith
product
np
vlpbase
vaccin
emerg
reemerg
viral
infect
studi
carri
accord
recommend
ministri
food
drug
safeti
mfd
republ
korea
protocol
approv
ylarc
institut
anim
care
use
committe
iacuc
permit
number
ysk
bs
design
research
studi
ysk
bs
wrote
manuscript
ysk
perform
overal
experi
jhk
jek
sk
yb
js
conduct
research
studi
jl
jy
provid
technic
assist
vector
pk
develop
necessari
softwar
perform
analyz
comput
data
cp
provid
technic
assist
conduct
rnase
treatment
experi
yk
nc
provid
patient
sera
infect
merscov
mk
jc
analyz
cellular
immun
respons
flow
cytometri
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
